Peter Johnson to Fentanyl
This is a "connection" page, showing publications Peter Johnson has written about Fentanyl.
Connection Strength
3.853
-
"Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". Ann Pharmacother. 2022 03; 56(3):370-371.
Score: 0.737
-
Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021 04; 41(4):359-369.
Score: 0.728
-
Conversion From Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. Ann Pharmacother. 2021 12; 55(12):1439-1446.
Score: 0.724
-
Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Pediatr Crit Care Med. 2019 12; 20(12):e556-e564.
Score: 0.662
-
Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. Am J Health Syst Pharm. 2017 Aug 01; 74(15):1174-1183.
Score: 0.557
-
Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. J Opioid Manag. 2010 Mar-Apr; 6(2):117-24.
Score: 0.337
-
Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. Ann Pharmacother. 2014 Mar; 48(3):335-42.
Score: 0.109